{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:46:50Z","timestamp":1773370010328,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bneo.2025.100182","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T21:27:29Z","timestamp":1762464449000},"page":"100182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitors"],"prefix":"10.1016","volume":"3","author":[{"given":"Alex C. H.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severine","family":"Cathelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhanoop","family":"Manikoth Ayyathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yitong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzaneh","family":"Aboualizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Abow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurbaksh","family":"Basi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2801-1521","authenticated-orcid":false,"given":"Lance","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6535-6888","authenticated-orcid":false,"given":"Abdula","family":"Maher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Grignano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1686-8512","authenticated-orcid":false,"given":"Mohsen","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troy","family":"Ketela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan M.","family":"Marchione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9506-2121","authenticated-orcid":false,"given":"Adriana E.","family":"Tron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9089-8816","authenticated-orcid":false,"given":"Mark D.","family":"Minden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bneo.2025.100182_bib1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.seminhematol.2015.03.008","article-title":"Biology and clinical relevance of acute myeloid leukemia stem cells","volume":"52","author":"Reinisch","year":"2015","journal-title":"Semin Hematol"},{"issue":"6","key":"10.1016\/j.bneo.2025.100182_bib2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12185-013-1407-8","article-title":"Role of DNMT3A, TET2, and IDH1\/2 mutations in pre-leukemic stem cells in acute myeloid leukemia","volume":"98","author":"Chan","year":"2013","journal-title":"Int J Hematol"},{"issue":"7834","key":"10.1016\/j.bneo.2025.100182_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","article-title":"Single-cell mutation analysis of clonal evolution in myeloid malignancies","volume":"587","author":"Miles","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bneo.2025.100182_bib4","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1038\/s41467-020-19119-8","article-title":"Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics","volume":"11","author":"Morita","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.bneo.2025.100182_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccr.2014.01.031","article-title":"Functional heterogeneity of genetically defined subclones in acute myeloid leukemia","volume":"25","author":"Klco","year":"2014","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.bneo.2025.100182_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","article-title":"Evolution of the cancer stem cell model","volume":"14","author":"Kreso","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bneo.2025.100182_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/B978-0-12-462001-8.50008-9","article-title":"Immune-deficient mice as models for human hematopoietic disease","volume":"1","author":"Dick","year":"1991","journal-title":"Mol Genet Med"},{"issue":"7","key":"10.1016\/j.bneo.2025.100182_bib8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.bneo.2025.100182_bib9","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/s41467-022-29304-6","article-title":"Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells","volume":"13","author":"Kawashima","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bneo.2025.100182_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41467-019-14106-0","article-title":"Clonal competition within complex evolutionary hierarchies shapes AML over time","volume":"11","author":"Sand\u00e9n","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.bneo.2025.100182_bib11","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1101\/gr.232272.117","article-title":"High-throughput single-cell DNA sequencing of acute myeloid leukemia tumors with droplet microfluidics","volume":"28","author":"Pellegrino","year":"2018","journal-title":"Genome Res"},{"key":"10.1016\/j.bneo.2025.100182_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13059-016-0936-x","article-title":"Tree inference for single-cell data","volume":"17","author":"Jahn","year":"2016","journal-title":"Genome Biol"},{"issue":"4","key":"10.1016\/j.bneo.2025.100182_bib13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/2643-3230.BCD-22-0205","article-title":"A phase Ib\/II study of ivosidenib with venetoclax +\/- azacitidine in IDH1-mutated myeloid malignancies","volume":"4","author":"Lachowiez","year":"2023","journal-title":"Blood Cancer Discov"},{"issue":"16","key":"10.1016\/j.bneo.2025.100182_bib14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa2117344","article-title":"Ivosidenib and azacitidine in IDH1-mutated acute myeloid leukemia","volume":"386","author":"Montesinos","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bneo.2025.100182_bib15","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1016\/j.csbj.2022.06.013","article-title":"Somatic variant calling from single-cell DNA sequencing data","volume":"20","author":"Valecha","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"issue":"23","key":"10.1016\/j.bneo.2025.100182_bib16","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1158\/0008-5472.CAN-22-1293","article-title":"Targeting STAT5 signaling overcomes resistance to IDH inhibitors in acute myeloid leukemia through suppression of stemness","volume":"82","author":"Liu","year":"2022","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.bneo.2025.100182_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0888-7543(92)90313-H","article-title":"The genomic organization and expression of the WT1 gene","volume":"12","author":"Gessler","year":"1992","journal-title":"Genomics"},{"issue":"19","key":"10.1016\/j.bneo.2025.100182_bib18","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1182\/blood-2008-10-183392","article-title":"Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group","volume":"113","author":"Gaidzik","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bneo.2025.100182_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-0716-1771-7_12","article-title":"High-throughput multimodal single-cell targeted DNA and surface protein analysis using the Mission Bio Tapestri platform","volume":"2386","author":"Ruff","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1016\/j.bneo.2025.100182_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3109\/08923979909007126","article-title":"CD69 and regulation of the immune function","volume":"21","author":"Marzio","year":"1999","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"25","key":"10.1016\/j.bneo.2025.100182_bib21","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","article-title":"Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML","volume":"378","author":"DiNardo","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.bneo.2025.100182_bib22","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1182\/bloodadvances.2020001503","article-title":"Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML","volume":"4","author":"Choe","year":"2020","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.bneo.2025.100182_bib23","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1158\/2159-8290.CD-18-0877","article-title":"Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition","volume":"8","author":"Harding","year":"2018","journal-title":"Cancer Discov"},{"issue":"5","key":"10.1016\/j.bneo.2025.100182_bib24","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/2159-8290.CD-16-1034","article-title":"AG-221, a first-in-class therapy targeting acute myeloid leukemia harboring oncogenic IDH2 mutations","volume":"7","author":"Yen","year":"2017","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1016\/j.bneo.2025.100182_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.immuni.2020.07.017","article-title":"Coexpression of CD71 and CD117 identifies an early unipotent neutrophil progenitor population in human bone marrow","volume":"53","author":"Dinh","year":"2020","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.bneo.2025.100182_bib26","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1158\/1078-0432.CCR-21-3467","article-title":"Impact of venetoclax and azacitidine in treatment-na\u00efve patients with acute myeloid leukemia and IDH1\/2 mutations","volume":"28","author":"Pollyea","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.bneo.2025.100182_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2025.100152","article-title":"Ivosidenib or venetoclax combined with hypomethylating agents in IDH1-mutated acute myeloid leukemia: a real-world study","volume":"2","author":"Lachowiez","year":"2025","journal-title":"Blood Neoplasia"},{"issue":"4","key":"10.1016\/j.bneo.2025.100182_bib28","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.molcel.2014.12.023","article-title":"WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation","volume":"57","author":"Wang","year":"2015","journal-title":"Mol Cell"},{"issue":"4","key":"10.1016\/j.bneo.2025.100182_bib29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/acsmedchemlett.7b00421","article-title":"Discovery of AG-120 (ivosidenib): a first-in-class mutant IDH1 inhibitor for the treatment of IDH1 mutant cancers","volume":"9","author":"Popovici-Muller","year":"2018","journal-title":"ACS Med Chem Lett"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:48:31Z","timestamp":1771465711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328025001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2950328025001177"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100182","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitors","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100182"}}